- Previous Close
35.30 - Open
34.55 - Bid 36.26 x --
- Ask 36.27 x --
- Day's Range
34.43 - 36.58 - 52 Week Range
28.11 - 46.84 - Volume
7,697,576 - Avg. Volume
1,989,203 - Market Cap (intraday)
6.401B - Beta (5Y Monthly) 0.10
- PE Ratio (TTM)
25.36 - EPS (TTM)
1.43 - Earnings Date --
- Forward Dividend & Yield 0.58 (1.60%)
- Ex-Dividend Date Jul 1, 2024
- 1y Target Est
--
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry, and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.
www.eastonpharma.cnRecent News: 688513.SS
View MorePerformance Overview: 688513.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688513.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688513.SS
View MoreValuation Measures
Market Cap
6.40B
Enterprise Value
5.16B
Trailing P/E
25.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.87
Price/Book (mrq)
2.39
Enterprise Value/Revenue
3.95
Enterprise Value/EBITDA
19.43
Financial Highlights
Profitability and Income Statement
Profit Margin
17.54%
Return on Assets (ttm)
--
Return on Equity (ttm)
8.96%
Revenue (ttm)
1.35B
Net Income Avi to Common (ttm)
236.57M
Diluted EPS (ttm)
1.43
Balance Sheet and Cash Flow
Total Cash (mrq)
1.41B
Total Debt/Equity (mrq)
6.24%
Levered Free Cash Flow (ttm)
--